 |
 |

Dextran 40 in the Treatment of Peripheral Vascular Diseases
John M. Thomas, MD;
Joao R. Silva, MD
AMA Arch Surg. 1973;106(2):138-141.
Abstract
Following a fatality from renal shutdown in an 87-year-old patient receiving dextran 40, the authors have established a routine of administration based on individual variations in tolerance. This was successful in 75 subsequent patients, adjusting the hourly dosage of dextran 40 on the basis of hourly urine outputs and specific gravities. As long as the specific gravity remained under 1.030 and the hourly volume over 25 ml, the dosages were gradually increased up to a maximum of 50 ml/hr.
Author Affiliations
Sayre, Pa
From the Robert Packer Hospital (Drs. Thomas and Silva)-Guthrie Clinic Ltd. (Dr. Thomas), Sayre, Pa.
Footnotes
Accepted for publication Aug 15, 1972.
Reprint requests to Guthrie Clinic Ltd., Sayre, Pa 18840 (Dr. Thomas).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Dextran in Vascular Surgery
Bergentz and Bergqvist
VASC ENDOVASCULAR SURG 1984;18:51-56.
ABSTRACT
Drugs Five Years Later: Dextran 40
DATA and NIES
ANN INTERN MED 1974;81:500-504.
ABSTRACT
|